| Record ID | ia:fluoropyrimidine0000unse |
| Source | Internet Archive |
| Download MARC XML | https://archive.org/download/fluoropyrimidine0000unse/fluoropyrimidine0000unse_marc.xml |
| Download MARC binary | https://www.archive.org/download/fluoropyrimidine0000unse/fluoropyrimidine0000unse_meta.mrc |
LEADER: 01245cam a22003374a 4500
001 2002017289
003 DLC
005 20080311121206.0
008 020212s2003 njua b 001 0 eng
010 $a 2002017289
020 $a0896039560 (alk. paper)
035 $a(DNLM)101138031
040 $aDNLM/DLC$cDLC$dDLC
042 $apcc
050 00 $aRC271.F55$bF58 2003
060 10 $aWI 529$bF646 2002
082 00 $a616.99/4061$221
245 00 $aFluoropyrimidines in cancer therapy /$cedited by Youcef M. Rustum.
260 $aTotowa, N.J. :$bHumana Press,$cc2003.
300 $axii, 325 p. :$bill. ;$c26 cm.
440 0 $aCancer drug discovery and development
504 $aIncludes bibliographical references and index.
650 0 $aFluoropyrimidines$xTherapeutic use.
650 0 $aCancer$xChemotherapy.
650 12 $aColorectal Neoplasms$xdrug therapy.
650 12 $aFluorouracil$xtherapeutic use.
650 22 $aAntimetabolites, Antineoplastic$xtherapeutic use.
650 22 $aImmunosuppressive Agents$xtherapeutic use.
700 1 $aRustum, Youcef M.
856 41 $3Table of contents$uhttp://www.loc.gov/catdir/toc/fy034/2002017289.html
856 42 $3Publisher description$uhttp://www.loc.gov/catdir/enhancements/fy0825/2002017289-d.html